Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1968 1
1970 1
1971 1
1973 1
1975 6
1976 2
1977 3
1978 3
1979 5
1980 10
1981 8
1982 12
1983 14
1984 13
1985 12
1986 9
1987 12
1988 5
1989 16
1990 15
1991 9
1992 13
1993 17
1994 13
1995 14
1996 14
1997 12
1998 14
1999 23
2000 14
2001 10
2002 36
2003 39
2004 24
2005 33
2006 28
2007 35
2008 50
2009 50
2010 52
2011 43
2012 68
2013 69
2014 69
2015 90
2016 89
2017 118
2018 104
2019 84
2020 97
2021 112
2022 97
2023 85
2024 45

Text availability

Article attribute

Article type

Publication date

Search Results

1,608 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Hypertrophic cardiomyopathy 10"
Page 1
Hypertrophic cardiomyopathy: a systematic review.
Maron BJ. Maron BJ. JAMA. 2002 Mar 13;287(10):1308-20. doi: 10.1001/jama.287.10.1308. JAMA. 2002. PMID: 11886323 Review.
CONTEXT: Throughout the past 40 years, a vast and sometimes contradictory literature has accumulated regarding hypertrophic cardiomyopathy (HCM), a genetic cardiac disease caused by a variety of mutations in genes encoding sarcomeric proteins and characterized by a …
CONTEXT: Throughout the past 40 years, a vast and sometimes contradictory literature has accumulated regarding hypertrophic cardio …
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy.
Maron MS, Masri A, Choudhury L, Olivotto I, Saberi S, Wang A, Garcia-Pavia P, Lakdawala NK, Nagueh SF, Rader F, Tower-Rader A, Turer AT, Coats C, Fifer MA, Owens A, Solomon SD, Watkins H, Barriales-Villa R, Kramer CM, Wong TC, Paige SL, Heitner SB, Kupfer S, Malik FI, Meng L, Wohltman A, Abraham T; REDWOOD-HCM Steering Committee and Investigators. Maron MS, et al. J Am Coll Cardiol. 2023 Jan 3;81(1):34-45. doi: 10.1016/j.jacc.2022.10.020. J Am Coll Cardiol. 2023. PMID: 36599608 Free article. Clinical Trial.
BACKGROUND: Left ventricular outflow tract (LVOT) obstruction is a major determinant of heart failure symptoms in obstructive hypertrophic cardiomyopathy (oHCM). Aficamten, a next-in-class cardiac myosin inhibitor, may lower gradients and improve symptoms in these p …
BACKGROUND: Left ventricular outflow tract (LVOT) obstruction is a major determinant of heart failure symptoms in obstructive hypertrophi …
Echocardiography in the Diagnosis and Management of Hypertrophic Cardiomyopathy.
Rakowski H, Hoss S, Williams LK. Rakowski H, et al. Cardiol Clin. 2019 Feb;37(1):11-26. doi: 10.1016/j.ccl.2018.09.001. Cardiol Clin. 2019. PMID: 30447711 Review.
Hypertrophic cardiomyopathy (HCM) is an inherited condition present in about 1/500 individuals with more than 1500 causative mutations identified in primarily 10 sarcomeric proteins. ...
Hypertrophic cardiomyopathy (HCM) is an inherited condition present in about 1/500 individuals with more than 1500 causative m …
Current and emerging perspectives on pathophysiology, diagnosis, and management of hypertrophic cardiomyopathy.
Gartzonikas IK, Naka KK, Anastasakis A. Gartzonikas IK, et al. Hellenic J Cardiol. 2023 Mar-Apr;70:65-74. doi: 10.1016/j.hjc.2022.11.002. Epub 2022 Nov 17. Hellenic J Cardiol. 2023. PMID: 36403865 Free article. Review.
Hypertrophic cardiomyopathy (HCM) is the most common genetically inherited cardiomyopathy with an autosomal dominant inheritance pattern. ...
Hypertrophic cardiomyopathy (HCM) is the most common genetically inherited cardiomyopathy with an autosomal dominant in …
Hypokinetic hypertrophic cardiomyopathy: clinical phenotype, genetics, and prognosis.
Wasserstrum Y, Larrañaga-Moreira JM, Martinez-Veira C, Itelman E, Lotan D, Sabbag A, Kuperstein R, Peled Y, Freimark D, Barriales-Villa R, Arad M. Wasserstrum Y, et al. ESC Heart Fail. 2022 Aug;9(4):2301-2312. doi: 10.1002/ehf2.13914. Epub 2022 Apr 30. ESC Heart Fail. 2022. PMID: 35488723 Free PMC article.
AIMS: To describe the phenotype, genetics, and events associated with the development of hypertrophic cardiomyopathy (HCM) with reduced ventricular function (HCMr). ...Patients who developed HCMr in the course of the study had similar mortality but a higher rate of …
AIMS: To describe the phenotype, genetics, and events associated with the development of hypertrophic cardiomyopathy (HCM) wit …
New Developments in Hypertrophic Cardiomyopathy.
Cooper RM, Raphael CE, Liebregts M, Anavekar NS, Veselka J. Cooper RM, et al. Can J Cardiol. 2017 Oct;33(10):1254-1265. doi: 10.1016/j.cjca.2017.07.007. Epub 2017 Jul 20. Can J Cardiol. 2017. PMID: 28941606 Review.
Hypertrophic cardiomyopathy is the leading cause of sudden death in young individuals and an important cause of heart failure at any age. ...Myocardial perfusion abnormalities are known to predict adverse outcome in hypertrophic cardiomyopathy and we d …
Hypertrophic cardiomyopathy is the leading cause of sudden death in young individuals and an important cause of heart failure …
Phenotypic variation and targeted therapy of hypertrophic cardiomyopathy using genetic animal models.
Gannon MP, Link MS. Gannon MP, et al. Trends Cardiovasc Med. 2021 Jan;31(1):20-31. doi: 10.1016/j.tcm.2019.11.009. Epub 2019 Nov 28. Trends Cardiovasc Med. 2021. PMID: 31862214 Review.
Hypertrophic cardiomyopathy (HCM) has a variable clinical presentation due to the diversity of causative genetic mutations. ...
Hypertrophic cardiomyopathy (HCM) has a variable clinical presentation due to the diversity of causative genetic mutations. .. …
Update on hypertrophic cardiomyopathy and a guide to the guidelines.
Sen-Chowdhry S, Jacoby D, Moon JC, McKenna WJ. Sen-Chowdhry S, et al. Nat Rev Cardiol. 2016 Nov;13(11):651-675. doi: 10.1038/nrcardio.2016.140. Epub 2016 Sep 29. Nat Rev Cardiol. 2016. PMID: 27681577 Review.
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disorder, affecting 1 in 500 individuals worldwide. ...
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disorder, affecting 1 in 500 individuals worldwi …
Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy.
Puckelwartz MJ, Pesce LL, Dellefave-Castillo LM, Wheeler MT, Pottinger TD, Robinson AC, Kearns SD, Gacita AM, Schoppen ZJ, Pan W, Kim G, Wilcox JE, Anderson AS, Ashley EA, Day SM, Cappola T, Dorn GW 2nd, McNally EM. Puckelwartz MJ, et al. J Am Heart Assoc. 2021 Apr 6;10(7):e019944. doi: 10.1161/JAHA.120.019944. Epub 2021 Mar 25. J Am Heart Assoc. 2021. PMID: 33764162 Free PMC article.
To evaluate the genetic contribution to this variable expression, we compared protein coding variation in the genomes of those with hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). Methods and Results Nonsynonymous single-nucleotide variant …
To evaluate the genetic contribution to this variable expression, we compared protein coding variation in the genomes of those with hyper …
Echocardiographic evaluation of hypertrophic cardiomyopathy: A review of up-to-date knowledge and practical tips.
Anwar AM, tenCate FJ. Anwar AM, et al. Echocardiography. 2021 Oct;38(10):1795-1808. doi: 10.1111/echo.15200. Epub 2021 Sep 23. Echocardiography. 2021. PMID: 34555207 Review.
Hypertrophic cardiomyopathy (HCM) is the most frequent cardiac disease with genetic substrate, affecting about .2%-.5% of the population. ...
Hypertrophic cardiomyopathy (HCM) is the most frequent cardiac disease with genetic substrate, affecting about .2%-.5% of the …
1,608 results